Total Payments
$941,534
2024 Payments
$54,536
Companies
43
Transactions
1,684
Medicare Patients
3,400
Medicare Billing
$907,414
Payment Breakdown by Category
Other$648,376 (68.9%)
Consulting$95,372 (10.1%)
Research$83,851 (8.9%)
Travel$68,501 (7.3%)
Food & Beverage$39,771 (4.2%)
Education$5,649 (0.6%)
Gifts$15.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $426,948 | 207 | 45.3% |
| Honoraria | $220,128 | 104 | 23.4% |
| Consulting Fee | $95,372 | 44 | 10.1% |
| Unspecified | $83,851 | 48 | 8.9% |
| Travel and Lodging | $68,501 | 333 | 7.3% |
| Food and Beverage | $39,771 | 936 | 4.2% |
| Education | $5,649 | 9 | 0.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,300 | 2 | 0.1% |
| Gift | $15.00 | 1 | 0.0% |
Payments by Type
General
$857,683
1,636 transactions
Research
$83,851
48 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $184,260 | 265 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $152,948 | 229 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $106,159 | 145 | $0 (2024) |
| Lundbeck LLC | $99,864 | 176 | $0 (2021) |
| Kyowa Kirin, Inc. | $73,739 | 98 | $0 (2024) |
| US WorldMeds, LLC | $70,856 | 135 | $0 (2020) |
| MDD US Operations, LLC | $56,274 | 84 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $53,233 | 62 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $51,239 | 76 | $0 (2021) |
| Impax Laboratories, Inc. | $23,832 | 32 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54,536 | 160 | Neurocrine Biosciences, Inc. ($20,781) |
| 2023 | $84,541 | 134 | MDD US Operations, LLC ($36,260) |
| 2022 | $66,738 | 149 | Kyowa Kirin, Inc. ($32,726) |
| 2021 | $153,442 | 196 | Neurocrine Biosciences, Inc. ($76,533) |
| 2020 | $103,761 | 185 | ACADIA Pharmaceuticals Inc ($35,869) |
| 2019 | $176,191 | 278 | ACADIA Pharmaceuticals Inc ($46,459) |
| 2018 | $164,997 | 294 | Neurocrine Biosciences, Inc. ($30,460) |
| 2017 | $137,327 | 288 | Lundbeck LLC ($52,189) |
All Payment Transactions
1,684 individual payment records from CMS Open Payments — Page 1 of 68
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROLOGY | ||||||
| 12/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $135.55 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $128.01 | General |
| Category: Neuromodulation | ||||||
| 12/17/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $124.04 | General |
| Category: Neuromodulation | ||||||
| 12/09/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $30.66 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $121.84 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $38.49 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: NEUROLOGY | ||||||
| 11/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: Neurology | ||||||
| 10/31/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Neuropsychiatry | ||||||
| 10/28/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $330.00 | General |
| Category: NEUROLOGY | ||||||
| 10/28/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Musculoskeletal | ||||||
| 10/24/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: NEUROLOGY | ||||||
| 10/18/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $145.05 | General |
| Category: Neuromodulation | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: Neuropsychiatry | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: Neuropsychiatry | ||||||
| 10/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $127.95 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $56.28 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Travel and Lodging | In-kind items and services | $52.00 | General |
| Category: NEUROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACA 16-cAC-0001 | ACADIA Pharmaceuticals Inc | $24,901 | 16 |
| Xadago Pro-Go | US WorldMeds, LLC | $17,980 | 3 |
| TV50717-CNS-40189 | Teva Pharmaceuticals USA, Inc. | $11,743 | 2 |
| Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension RESTORE | Lundbeck LLC | $11,603 | 1 |
| ACP-103-048 | ACADIA Pharmaceuticals Inc | $11,558 | 9 |
| ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE | Eli Lilly and Company | $1,681 | 1 |
| Myobloc Sialorrhea OL Protocol SN-SIAL-351 | US WorldMeds, LLC | $1,657 | 1 |
| ACP-103-063 | ACADIA Pharmaceuticals Inc | $1,338 | 13 |
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND DELAYED-START STUDY OF LY3314814 IN MILD ALZHEIMERS DISEASE DEMENTIA | Eli Lilly and Company | $1,291 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 825 | 12,830 | $441,560 | $223,983 |
| 2022 | 17 | 797 | 8,381 | $388,320 | $197,241 |
| 2021 | 13 | 850 | 5,473 | $398,750 | $211,193 |
| 2020 | 17 | 928 | 20,876 | $566,486 | $274,997 |
Total Patients
3,400
Total Services
47,560
Medicare Billing
$907,414
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 606 | $106,050 | $57,724 | 54.4% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2023 | 16 | 4,680 | $65,520 | $31,123 | 47.5% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2023 | 30 | 2,650 | $39,750 | $26,419 | 66.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 135 | 190 | $42,750 | $25,420 | 59.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 11 | 4,100 | $32,800 | $20,389 | 62.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 124 | 124 | $43,375 | $19,956 | 46.0% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 35 | 87 | $32,190 | $12,337 | 38.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 34 | 34 | $27,200 | $9,809 | 36.1% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 18 | 41 | $9,225 | $5,335 | 57.8% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 32 | 66 | $8,250 | $3,877 | 47.0% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 15 | 79 | $5,925 | $2,736 | 46.2% |
| 64646 | Injection of chemical for paralysis of nerve muscles on trunk, 1-5 muscles | Office | 2023 | 17 | 35 | $8,400 | $2,655 | 31.6% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 24 | 49 | $6,615 | $2,263 | 34.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 24 | $6,720 | $2,263 | 33.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 15 | 29 | $3,190 | $1,162 | 36.4% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 23 | 36 | $3,600 | $514.70 | 14.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 291 | 646 | $113,050 | $62,486 | 55.3% |
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2022 | 14 | 4,700 | $65,800 | $31,397 | 47.7% |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | Office | 2022 | 26 | 2,325 | $34,875 | $22,421 | 64.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 119 | 163 | $36,675 | $21,470 | 58.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 114 | 114 | $37,300 | $18,522 | 49.7% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 33 | 80 | $29,600 | $11,673 | 39.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 29 | 29 | $23,200 | $8,540 | 36.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 15 | 34 | $7,650 | $4,889 | 63.9% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 30 | 64 | $8,000 | $3,982 | 49.8% |
About Dr. Ramon Gil, MD
Dr. Ramon Gil, MD is a Specialist healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700847597.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramon Gil, MD has received a total of $941,534 in payments from pharmaceutical and medical device companies, with $54,536 received in 2024. These payments were reported across 1,684 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($426,948).
As a Medicare-enrolled provider, Gil has provided services to 3,400 Medicare beneficiaries, totaling 47,560 services with total Medicare billing of $907,414. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Port Charlotte, FL
- Active Since 03/31/2006
- Last Updated 10/09/2012
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1700847597
Products in Payments
- NUPLAZID (Drug) $152,948
- INGREZZA (Drug) $116,481
- RYTARY (Drug) $105,680
- NORTHERA (Drug) $99,735
- GOCOVRI (Drug) $88,043
- NOURIANZ (Drug) $65,595
- ONGENTYS (Drug) $57,391
- AUSTEDO (Drug) $48,831
- Xadago (Drug) $46,419
- Gocovri (Drug) $19,316
- MYOBLOC (Biological) $13,847
- Dysport (Drug) $10,734
- APOKYN (Drug) $10,718
- Duopa (Drug) $8,635
- INFINITY (Device) $8,293
- Nourianz (Drug) $8,143
- CREXONT (Drug) $7,631
- DUOPA (Drug) $6,783
- KYNMOBI (Drug) $6,575
- DYSPORT (Drug) $4,028
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Port Charlotte
Liliana Montoya, Md, MD
Specialist — Payments: $12,772
Specialist $12,772
George Li, M.d, M.D
Specialist — Payments: $12,489
Specialist $12,489
Mario Lopez, Md, MD
Specialist — Payments: $10,489
Specialist $10,489
Dr. Louis Valente, M.d, M.D
Specialist — Payments: $6,500
Specialist $6,500
Ricardo Martinez, Md, MD
Specialist — Payments: $5,361
Specialist $5,361
Andrew Obermeier, Pa, PA
Specialist — Payments: $3,722
Specialist $3,722